Locally administered antimicrobials for the management of periodontal infection

Dentistry Today

Volumn 28, Issue 2, 2009, Pages

  Paquette, David W ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; MICROSPHERE; RETINA S ANTIGEN;

GRAM NEGATIVE INFECTION; HUMAN; PERIODONTITIS; SHORT SURVEY;

ANTI-BACTERIAL AGENTS; ARRESTIN; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROSPHERES; PERIODONTITIS;

EID: 61449194458     PISSN: 87502186     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (31)

1. Paqaette DW. Pocket depth reduction as an outcome measure of inflammation and soft tissue changes in periodontitis trials. J Int Acad Periodontal 2005;7(4 suppl):147-156.
2. D'Aiuto F, Nibali L, Parkar M, et al. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res. 2005;84:269-273.
3. Tonetti MS, D'Aiuto F, Nibali L, et al. Treatment of periodontitis and endothelial function. N Engl J Med. 2007;356:911-920.
4. Albandar JM, Brunelle JA, Kingman A. Destructive periodontal disease in adults 30 years of age and older in the United States, 1988-1994 [published correction appears in J Periodontal. Mar 1999:70:351]. J Periodontal. Jan 1999;70:13-29.
5. Flemmig TF. Periodontitis. Ann Periodontal. 1999;4:32-38.
6. Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000. 2005;38:135-187.
7. Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontal. 1996;1:821-878.
8. Slade GD, Offenbacher S, Beck JD, et al. Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res. 2000;79:49-57.
9. Pussinen PJ, Tuomisto K, Jousilahti P, et al. Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associated with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol. 2007;27:1433-1439.
10. Socransky SS, Haffajee AD, Goodson JM, et al. New concepts of destructive periodontal disease. J Clin Periodontol. 1984;11:21-32.
11. Research, Science and Therapy Committee of the American Academy of Periodontology. Position paper: tobacco use and the periodontal patient. J Periodontol. 1999;70:1419-1427.
12. Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: a two-way relationship. Ann Periodontal. 1998;3:51-61.
13. Saito T, Shimazaki Y, Sakamoto M. Obesity and periodontitis. N Engl J Med. 1998;482-483.
14. Ramfjord SP, Morrison EC, Burgett FG, et al. Oral hygiene and maintenance of periodontal support. J Periodontal. 1982;53:26-30.
15. Kornman KS, Crane A, Wang HY, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol. 1997;24:72-77.
16. Paulander J, Axelsson P, Lindhe J, et al. Intraoral pattern of tooth and periodontal bone loss between the age of 50 and 60 years. A longitudinal prospective study. Acta Odontol Scand. 2004;62:214-222.
17. Cobb CM. Non-surgical pocket therapy: mechanical. Ann Periodontol. 1996;1:443-490.
18. Palcanis KG. Surgical pocket therapy. Ann Periodontol. 1996;1:589-617.
19. Drisko CH. Non-surgical pocket therapy: pharmacotherapeutics. Ann Periodontol. 1996;1:491-566.
20. Haffajee AD, Socransky SS, Gunsolley JC. Systemic anti-infective periodontal therapy. A systematic review. Ann Periodontol. 2003;8:115-181.
21. Goodson JM, Cugini MA, Kent RL, et al. Multicenter evaluation of tetracycline fiber therapy: II. Clinical response. J Periodontal Res. 1991;26:371-379.
22. Jeffcoat MK, Bray KS, Ciancio SG, et al. Adjunctive use of a subgingival controlled-release chlorhexidine chip reduces probing depth and improves attachment level compared with scaling and root planing alone. J Periodontol. 1998;69:989-997.
23. Garrett S, Johnson L, Drisko CH, et al. Two multi-center studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, and scaling and root planing in the treatment of periodontitis. J Periodontol. 1999;70:490-503.
24. Williams RC, Paquette DW, Offenbacher S, et al. Treatment of periodontitis by local administration of minocycline microspheres: a controlled trial. J Periodontol. 2001 ;72:1535-1544.
25. Hanes PJ, Purvis JP. Local anti-infective therapy: pharmacological agents. A systematic review. Ann Periodontol. 2003;8:79-98.
26. Goodson JM, Gunsolley JC, Grossi SG, et al. Minocycline HCI microspheres reduce red-complex bacteria in periodontal disease therapy. J Periodontol. 2007;78:1568-1579.
27. Grossi SG, Goodson JM, Gunsolley JC, et al. Mechanical therapy with adjunctive minocycline microspheres reduces red-complex bacteria in smokers. J Periodontol. 2007;78:1741-1750.
28. Oringer RJ, Al-Shammari KF, Aldredge WA, et al. Effects of locally delivered minocycline microspheres on markers of bone resorption. J Periodontol. 2002;73:835-842.
29. Paquette D, Oringer R, Lessem J, et al. Locally delivered minocycline microspheres for the treatment of periodontitis in smokers. J Clin Periodontol. 2003;30:787-794.
30. Paquette DW, Hanlon A, Lessem J, et al. Clinical relevance of adjunctive minocycline microspheres in patients with chronic periodontitis: secondary analysis of a phase 3 trial. J Periodontol. 2004;75:531-536.
31. Lessem J, Hanlon A. A post-marketing study of 2805 patients treated for periodontal disease with Arestin. J Int Acad Periodontol. 2004;6(4 suppl):150-153.